Top

Published in:

Open Access 25-03-2023 | Insulins | Review

Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders

Authors: Jacqueline M. Ratter-Rieck, Michael Roden, Christian Herder

Published in: Diabetologia | Issue 6/2023

Abstract

Climate change will be a major challenge for the world’s health systems in the coming decades. Elevated temperatures and increasing frequencies of heat waves, wildfires, heavy precipitation and other weather extremes can affect health in many ways, especially if chronic diseases are already present. Impaired responses to heat stress, including compromised vasodilation and sweating, diabetes-related comorbidities, insulin resistance and chronic low-grade inflammation make people with diabetes particularly vulnerable to environmental risk factors, such as extreme weather events and air pollution. Additionally, multiple pathogens show an increased rate of transmission under conditions of climate change and people with diabetes have an altered immune system, which increases the risk for a worse course of infectious diseases. In this review, we summarise recent studies on the impact of climate-change-associated risk for people with diabetes and discuss which individuals may be specifically prone to these risk conditions due to their clinical features. Knowledge of such high-risk groups will help to develop and implement tailored prevention and management strategies to mitigate the detrimental effect of climate change on the health of people with diabetes.

Graphical abstract

Available only for authorised users

Romanello M, McGushin A, Di Napoli C et al (2021) The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future. Lancet 398(10311):1619–1662. https://doi.org/10.1016/S0140-6736(21)01787-6CrossRefPubMed

Rousi E, Kornhuber K, Beobide-Arsuaga G, Luo F, Coumou D (2022) Accelerated western European heatwave trends linked to more-persistent double jets over Eurasia. Nat Commun 13(1):3851. https://doi.org/10.1038/s41467-022-31432-yCrossRefPubMedPubMedCentral

Thompson V, Kennedy-Asser AT, Vosper E et al (2022) The 2021 western North America heat wave among the most extreme events ever recorded globally. Sci Adv 8(18):eabm6860. https://doi.org/10.1126/sciadv.abm6860CrossRefPubMedPubMedCentral

Christidis N, McCarthy M, Stott PA (2020) The increasing likelihood of temperatures above 30 to 40 °C in the United Kingdom. Nat Commun 11(1):3093. https://doi.org/10.1038/s41467-020-16834-0CrossRefPubMedPubMedCentral

Ebi KL, Capon A, Berry P et al (2021) Hot weather and heat extremes: health risks. Lancet 398(10301):698–708. https://doi.org/10.1016/S0140-6736(21)01208-3CrossRefPubMed

Beulens JWJ, Pinho MGM, Abreu TC et al (2022) Environmental risk factors of type 2 diabetes-an exposome approach. Diabetologia 65(2):263–274. https://doi.org/10.1007/s00125-021-05618-wCrossRefPubMed

Romanello M, Di Napoli C, Drummond P et al (2022) The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels. Lancet 400(10363):1619–1654. https://doi.org/10.1016/S0140-6736(22)01540-9CrossRefPubMed

Sun H, Saeedi P, Karuranga S et al (2022) IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https://doi.org/10.1016/j.diabres.2021.109119CrossRefPubMed

Khraishah H, Alahmad B, Ostergard RLJ et al (2022) Climate change and cardiovascular disease: implications for global health. Nat Rev Cardiol. https://doi.org/10.1038/s41569-022-00720-x

10.

Schliess F, Reissmann R, Reinehr R, vom Dahl S, Häussinger D (2004) Involvement of integrins and Src in insulin signaling toward autophagic proteolysis in rat liver. J Biol Chem 279(20):21294–21301. https://doi.org/10.1074/jbc.M313901200CrossRefPubMed

11.

Schliess F, Häussinger D (2003) Cell volume and insulin signaling. Int Rev Cytol 225:187–228. https://doi.org/10.1016/s0074-7696(05)25005-2CrossRefPubMed

12.

Vanhaecke T, Perrier ET, Melander O (2020) A journey through the early evidence linking hydration to metabolic health. Ann Nutr Metab 76(Suppl 1):4–9. https://doi.org/10.1159/000515021CrossRefPubMed

13.

Nakamura K, Velho G, Bouby N (2017) Vasopressin and metabolic disorders: translation from experimental models to clinical use. J Intern Med 282(4):298–309. https://doi.org/10.1111/joim.12649CrossRefPubMed

14.

Roden M, Shulman GI (2019) The integrative biology of type 2 diabetes. Nature 576(7785):51–60. https://doi.org/10.1038/s41586-019-1797-8CrossRefPubMed

15.

Miyamura K, Nawa N, Nishimura H, Fushimi K, Fujiwara T (2022) Association between heat exposure and hospitalization for diabetic ketoacidosis, hyperosmolar hyperglycemic state, and hypoglycemia in Japan. Environ Int 167:107410. https://doi.org/10.1016/j.envint.2022.107410CrossRefPubMed

16.

Schrauwen P, van Marken Lichtenbelt WD (2016) Combatting type 2 diabetes by turning up the heat. Diabetologia 59(11):2269–2279. https://doi.org/10.1007/s00125-016-4068-3CrossRefPubMedPubMedCentral

17.

Georgiev A, Granata C, Roden M (2022) The role of mitochondria in the pathophysiology and treatment of common metabolic diseases in humans. Am J Physiol Cell Physiol 322(6):C1248–C1259. https://doi.org/10.1152/ajpcell.00035.2022CrossRefPubMed

18.

Pallubinsky H, Phielix E, Dautzenberg B et al (2020) Passive exposure to heat improves glucose metabolism in overweight humans. Acta Physiol 229(4):e13488. https://doi.org/10.1111/apha.13488CrossRef

19.

Sarabhai T, Mastrototaro L, Kahl S et al (2023) Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial. Diabetologia 66(1):57–69. https://doi.org/10.1007/s00125-022-05797-0CrossRefPubMed

20.

Kenny GP, Sigal RJ, McGinn R (2016) Body temperature regulation in diabetes. Temp 3(1):119–145. https://doi.org/10.1080/23328940.2015.1131506CrossRef

21.

Hoeldtke RD, Bryner KD, Horvath GG, Phares RW, Broy LF, Hobbs GR (2001) Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes 50(2):436–443. https://doi.org/10.2337/diabetes.50.2.436CrossRefPubMed

22.

Khan F, Elhadd TA, Greene SA, Belch JJ (2000) Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 23(2):215–220. https://doi.org/10.2337/diacare.23.2.215CrossRefPubMed

23.

Heimhalt-El Hamriti M, Schreiver C, Noerenberg A et al (2013) Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus. Cardiovasc Diabetol 12:115. https://doi.org/10.1186/1475-2840-12-115CrossRefPubMedPubMedCentral

24.

Shah AS, Gao Z, Dolan LM, Dabelea D, D’Agostino RBJ, Urbina EM (2015) Assessing endothelial dysfunction in adolescents and young adults with type 1 diabetes mellitus using a non-invasive heat stimulus. Pediatr Diabetes 16(6):434–440. https://doi.org/10.1111/pedi.12189CrossRefPubMed

25.

Arora S, Smakowski P, Frykberg RG et al (1998) Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care 21(8):1339–1344. https://doi.org/10.2337/diacare.21.8.1339CrossRefPubMed

26.

Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27(3):567–574. https://doi.org/10.1016/0735-1097(95)00522-6CrossRefPubMed

27.

Wick DE, Roberts SK, Basu A et al (2006) Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitus. J Appl Physiol 100(2):637–641. https://doi.org/10.1152/japplphysiol.00943.2005CrossRefPubMed

28.

Fredriksson I, Larsson M, Nyström FH, Länne T, Ostgren CJ, Strömberg T (2010) Reduced arteriovenous shunting capacity after local heating and redistribution of baseline skin blood flow in type 2 diabetes assessed with velocity-resolved quantitative laser Doppler flowmetry. Diabetes 59(7):1578–1584. https://doi.org/10.2337/db10-0080CrossRefPubMedPubMedCentral

29.

Fealey RD, Low PA, Thomas JE (1989) Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 64(6):617–628. https://doi.org/10.1016/s0025-6196(12)65338-5CrossRefPubMed

30.

Luo K-R, Chao C-C, Hsieh P-C, Lue J-H, Hsieh S-T (2012) Effect of glycemic control on sudomotor denervation in type 2 diabetes. Diabetes Care 35(3):612–616. https://doi.org/10.2337/dc11-1607CrossRefPubMedPubMedCentral

31.

Scott AR, MacDonald IA, Bennett T, Tattersall RB (1988) Abnormal thermoregulation in diabetic autonomic neuropathy. Diabetes 37(7):961–968. https://doi.org/10.2337/diab.37.7.961CrossRefPubMed

32.

Westaway K, Frank O, Husband A et al (2015) Medicines can affect thermoregulation and accentuate the risk of dehydration and heat-related illness during hot weather. J Clin Pharm Ther 40(4):363–367. https://doi.org/10.1111/jcpt.12294CrossRefPubMed

33.

Chen K, Dubrow R, Breitner S et al (2022) Triggering of myocardial infarction by heat exposure is modified by medication intake. Nat Cardiovasc Res 1(8):727–731. https://doi.org/10.1038/s44161-022-00102-zCrossRef

34.

Tabák AG, Akbaraly TN, Batty GD, Kivimäki M (2014) Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol 2(3):236–245. https://doi.org/10.1016/S2213-8587(13)70139-6CrossRefPubMed

35.

Blauw LL, Aziz NA, Tannemaat MR et al (2017) Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature. BMJ Open Diabetes Res Care 5(1):e000317. https://doi.org/10.1136/bmjdrc-2016-000317CrossRefPubMedPubMedCentral

36.

Valdés S, Doulatram-Gamgaram V, Lago A et al (2019) Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population: Di@bet.es study. Eur J Endocrinol 180(5):273–280. https://doi.org/10.1530/EJE-18-0818CrossRefPubMed

37.

Tucker P, Gilliland J (2007) The effect of season and weather on physical activity: a systematic review. Public Health 121(12):909–922. https://doi.org/10.1016/j.puhe.2007.04.009CrossRefPubMed

38.

Lee P, Smith S, Linderman J et al (2014) Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans. Diabetes 63(11):3686–3698. https://doi.org/10.2337/db14-0513CrossRefPubMedPubMedCentral

39.

Hanssen MJW, Hoeks J, Brans B et al (2015) Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat Med 21(8):863–865. https://doi.org/10.1038/nm.3891CrossRefPubMed

40.

Hajat S, Haines A, Sarran C, Sharma A, Bates C, Fleming LE (2017) The effect of ambient temperature on type-2-diabetes: case-crossover analysis of 4+ million GP consultations across England. Environ Health 16(1):73. https://doi.org/10.1186/s12940-017-0284-7CrossRefPubMedPubMedCentral

41.

Semenza JC, McCullough JE, Flanders WD, McGeehin MA, Lumpkin JR (1999) Excess hospital admissions during the July 1995 heat wave in Chicago. Am J Prev Med 16(4):269–277. https://doi.org/10.1016/s0749-3797(99)00025-2CrossRefPubMed

42.

Knowlton K, Rotkin-Ellman M, King G et al (2009) The 2006 California heat wave: impacts on hospitalizations and emergency department visits. Environ Health Perspect 117(1):61–67. https://doi.org/10.1289/ehp.11594CrossRefPubMed

43.

Basu R, Pearson D, Malig B, Broadwin R, Green R (2012) The effect of high ambient temperature on emergency room visits. Epidemiology 23(6):813–820. https://doi.org/10.1097/EDE.0b013e31826b7f97CrossRefPubMed

44.

Xu R, Zhao Q, Coelho MSZS et al (2019) Association between Heat exposure and hospitalization for diabetes in Brazil during 2000-2015: a nationwide case-crossover study. Environ Health Perspect 127(11):117005. https://doi.org/10.1289/EHP5688CrossRefPubMedPubMedCentral

45.

Schwartz J (2005) Who is sensitive to extremes of temperature?: A case-only analysis. Epidemiology 16(1):67–72. https://doi.org/10.1097/01.ede.0000147114.25957.71CrossRefPubMed

46.

Lam HCY, Chan JCN, Luk AOY, Chan EYY, Goggins WB (2018) Short-term association between ambient temperature and acute myocardial infarction hospitalizations for diabetes mellitus patients: A time series study. PLoS Med 15(7):e1002612. https://doi.org/10.1371/journal.pmed.1002612CrossRefPubMedPubMedCentral

47.

Natour S, Damri O, Agam G (2022) The effect of global warming on complex disorders (mental disorders, primary hypertension, and type 2 diabetes). Int J Environ Res Public Health 19(15):9398. https://doi.org/10.3390/ijerph19159398CrossRefPubMed

48.

Lu C-L, Chang H-H, Chen H-F et al (2016) Inverse relationship between ambient temperature and admissions for diabetic ketoacidosis and hyperglycemic hyperosmolar state: a 14-year time-series analysis. Environ Int 94:642–648. https://doi.org/10.1016/j.envint.2016.06.032CrossRefPubMed

49.

Kim K-N, Lim Y-H, Bae S et al (2022) Associations between cold spells and hospital admission and mortality due to diabetes: a nationwide multi-region time-series study in Korea. Sci Total Environ 838(Pt 3):156464. https://doi.org/10.1016/j.scitotenv.2022.156464CrossRefPubMed

50.

Liu Y, Wen H, Bai J, Shi F, Bi R, Yu C (2022) Burden of diabetes and kidney disease attributable to non-optimal temperature from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019. Sci Total Environ 838(Pt 3):156495. https://doi.org/10.1016/j.scitotenv.2022.156495CrossRefPubMed

51.

Seposo XT, Dang TN, Honda Y (2017) How does ambient air temperature affect diabetes mortality in tropical cities? Int J Environ Res Public Health 14(4):385. https://doi.org/10.3390/ijerph14040385CrossRefPubMedPubMedCentral

52.

Horton DE, Skinner CB, Singh D, Diffenbaugh NS (2014) Occurrence and persistence of future atmospheric stagnation events. Nat Clim Chang 4(8):698–703. https://doi.org/10.1038/nclimate2272CrossRefPubMedPubMedCentral

53.

Chen K, Wolf K, Breitner S et al (2018) Two-way effect modifications of air pollution and air temperature on total natural and cardiovascular mortality in eight European urban areas. Environ Int 116:186–196. https://doi.org/10.1016/j.envint.2018.04.021CrossRefPubMed

54.

Zhang S, Mwiberi S, Pickford R et al (2021) Longitudinal associations between ambient air pollution and insulin sensitivity: results from the KORA cohort study. Lancet Planet Heal 5(1):e39–e49. https://doi.org/10.1016/S2542-5196(20)30275-8CrossRef

55.

Lucht S, Hennig F, Moebus S et al (2020) All-source and source-specific air pollution and 10-year diabetes Incidence: total effect and mediation analyses in the Heinz Nixdorf recall study. Environ Int 136:105493. https://doi.org/10.1016/j.envint.2020.105493CrossRefPubMed

56.

Burkart K, Causey K, Cohen AJ et al (2022) Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019. Lancet Planet Heal 6(7):e586–e600. https://doi.org/10.1016/S2542-5196(22)00122-XCrossRef

57.

Herder C, Schneider A, Zhang S et al (2020) Association of long-term air pollution with prevalence and incidence of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Environ Health Perspect 128(12):127013. https://doi.org/10.1289/EHP7311CrossRefPubMedPubMedCentral

58.

Mahsin MD, Cabaj J, Saini V (2022) Respiratory and cardiovascular condition-related physician visits associated with wildfire smoke exposure in Calgary, Canada, in 2015: a population-based study. Int J Epidemiol 51(1):166–178. https://doi.org/10.1093/ije/dyab206CrossRefPubMed

59.

Johnston FH, Borchers-Arriagada N, Morgan GG et al (2021) Unprecedented health costs of smoke-related PM2.5 from the 2019–20 Australian megafires. Nat Sustain 4(1):42–47. https://doi.org/10.1038/s41893-020-00610-5CrossRef

60.

Malig BJ, Fairley D, Pearson D, Wu X, Ebisu K, Basu R (2021) Examining fine particulate matter and cause-specific morbidity during the 2017 North San Francisco Bay wildfires. Sci Total Environ 787:147507. https://doi.org/10.1016/j.scitotenv.2021.147507CrossRefPubMed

61.

Kopf S, Groener JB, Kender Z et al (2018) Breathlessness and restrictive lung disease: an important diabetes-related feature in patients with type 2 diabetes. Respiration 96(1):29–40. https://doi.org/10.1159/000488909CrossRefPubMed

62.

Röhling M, Pesta D, Markgraf DF et al (2018) Metabolic determinants of impaired pulmonary function in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 126(9):584–589. https://doi.org/10.1055/a-0653-7135CrossRefPubMed

63.

Peters U, Suratt BT, Bates JHT, Dixon AE (2018) Beyond BMI: obesity and lung disease. Chest 153(3):702–709. https://doi.org/10.1016/j.chest.2017.07.010CrossRefPubMed

64.

Peng C, Bind M-AC, Colicino E et al (2016) Particulate air pollution and fasting blood glucose in nondiabetic individuals: associations and epigenetic mediation in the Normative Aging Study, 2000-2011. Environ Health Perspect 124(11):1715–1721. https://doi.org/10.1289/EHP183CrossRefPubMedPubMedCentral

65.

Coumou D, Rahmstorf S (2012) A decade of weather extremes. Nat Clim Chang 2(7):491–496. https://doi.org/10.1038/nclimate1452CrossRef

66.

Fischer EM, Knutti R (2015) Anthropogenic contribution to global occurrence of heavy-precipitation and high-temperature extremes. Nat Clim Chang 5(6):560–564. https://doi.org/10.1038/nclimate2617CrossRef

67.

Ng J, Atkin SL, Rigby AS, Walton C, Kilpatrick ES (2011) The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes. Diabet Med 28(5):519–524. https://doi.org/10.1111/j.1464-5491.2011.03228.xCrossRefPubMed

68.

Tanaka M, Imai J, Satoh M et al (2014) Glycemic control in diabetic patients with impaired endogenous insulin secretory capacity is vulnerable after a natural disaster: study of Great East Japan Earthquake. Diabetes Care 37:e212–e213. https://doi.org/10.2337/dc14-1479CrossRefPubMed

69.

Fonseca VA, Smith H, Kuhadiya N et al (2009) Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences. Diabetes Care 32(9):1632–1638. https://doi.org/10.2337/dc09-0670CrossRefPubMedPubMedCentral

70.

Khunti K, Aroda VR, Aschner P et al (2022) The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Lancet Diabetes Endocrinol 10(12):890–900. https://doi.org/10.1016/S2213-8587(22)00278-9CrossRefPubMedPubMedCentral

71.

Khunti K, Feldman EL, Laiteerapong N, Parker W, Routen A, Peek M (2023) The impact of the COVID-19 pandemic on ethnic minority groups with diabetes. Diabetes Care 46(2):228–236. https://doi.org/10.2337/dc21-2495CrossRefPubMed

72.

Lee DC, Gupta VK, Carr BG et al (2016) Acute post-disaster medical needs of patients with diabetes: emergency department use in New York City by diabetic adults after Hurricane Sandy. BMJ Open Diabetes Res Care 4(1):e000248. https://doi.org/10.1136/bmjdrc-2016-000248CrossRefPubMedPubMedCentral

73.

Quast T, Andel R, Sadhu AR (2019) Long-term effects of disasters on seniors with diabetes: evidence from hurricanes Katrina and Rita. Diabetes Care 42(11):2090–2097. https://doi.org/10.2337/dc19-0567CrossRefPubMedPubMedCentral

74.

Hirai H, Okazaki K, Ohira T et al (2021) Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management Survey. BMJ Open Diabetes Res Care 9(1):e002007. https://doi.org/10.1136/bmjdrc-2020-002007CrossRefPubMedPubMedCentral

75.

Mora C, McKenzie T, Gaw IM et al (2022) Over half of known human pathogenic diseases can be aggravated by climate change. Nat Clim Chang 12(9):869–875. https://doi.org/10.1038/s41558-022-01426-1CrossRefPubMedPubMedCentral

76.

Rocklöv J, Dubrow R (2020) Climate change: an enduring challenge for vector-borne disease prevention and control. Nat Immunol 21(5):479–483. https://doi.org/10.1038/s41590-020-0648-yCrossRefPubMedPubMedCentral

77.

Semenza JC, Paz S (2021) Climate change and infectious disease in Europe: Impact, projection and adaptation. Lancet Reg Heal Eur 9:100230. https://doi.org/10.1016/j.lanepe.2021.100230CrossRef

78.

Kraemer MUG, Reiner RCJ, Brady OJ et al (2019) Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat Microbiol 4(5):854–863. https://doi.org/10.1038/s41564-019-0376-yCrossRefPubMedPubMedCentral

79.

Paull SH, Horton DE, Ashfaq M et al (2017) Drought and immunity determine the intensity of West Nile virus epidemics and climate change impacts. Proc Biol Sci 284(1848):20162078. https://doi.org/10.1098/rspb.2016.2078CrossRefPubMedPubMedCentral

80.

van Crevel R, van de Vijver S, Moore DAJ (2017) The global diabetes epidemic: what does it mean for infectious diseases in tropical countries? Lancet Diabetes Endocrinol 5(6):457–468. https://doi.org/10.1016/S2213-8587(16)30081-XCrossRefPubMed

81.

Menart-Houtermans B, Rütter R, Nowotny B et al (2014) Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 37(8):2326–2333. https://doi.org/10.2337/dc14-0316CrossRefPubMed

82.

Jagannathan-Bogdan M, McDonnell ME, Shin H et al (2011) Elevated proinflammatory cytokine production by a skewed t cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 186(2):1162–1172. https://doi.org/10.4049/jimmunol.1002615CrossRefPubMed

83.

Badawi A, Ryoo SG, Vasileva D, Yaghoubi S (2018) Prevalence of chronic comorbidities in chikungunya: a systematic review and meta-analysis. Int J Infect Dis 67:107–113. https://doi.org/10.1016/j.ijid.2017.12.018CrossRefPubMed

84.

Nash D, Mostashari F, Fine A et al (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344(24):1807–1814. https://doi.org/10.1056/NEJM200106143442401CrossRefPubMed

85.

Jean CM, Honarmand S, Louie JK, Glaser CA (2007) Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 13(12):1918–1920. https://doi.org/10.3201/eid1312.061265CrossRefPubMedPubMedCentral

86.

Kumar M, Roe K, Nerurkar PV et al (2012) Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus. PLoS One 7(8):e44682. https://doi.org/10.1371/journal.pone.0044682CrossRefPubMedPubMedCentral

87.

Kumar M, Roe K, Nerurkar PV et al (2014) Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus. J Neuroinflammation 11:80. https://doi.org/10.1186/1742-2094-11-80CrossRefPubMedPubMedCentral

88.

Geerling E, Stone ET, Steffen TL, Hassert M, Brien JD, Pinto AK (2021) Obesity enhances disease severity in female mice following West Nile virus infection. Front Immunol 12:739025. https://doi.org/10.3389/fimmu.2021.739025CrossRefPubMedPubMedCentral

89.

Pang J, Salim A, Lee VJ et al (2012) Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis 6(5):e1641. https://doi.org/10.1371/journal.pntd.0001641CrossRefPubMedPubMedCentral

90.

Figueiredo MAA, Rodrigues LC, Barreto ML et al (2010) Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis 4(6):e699. https://doi.org/10.1371/journal.pntd.0000699CrossRefPubMedPubMedCentral

91.

Chen C-Y, Lee M-Y, Lin K-D et al (2015) Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients. Int J Mol Sci 16(2):3820–3830. https://doi.org/10.3390/ijms16023820CrossRefPubMedPubMedCentral

92.

Pang J, Thein T-L, Leo Y-S, Lye DC (2014) Early clinical and laboratory risk factors of intensive care unit requirement during 2004-2008 dengue epidemics in Singapore: a matched case-control study. BMC Infect Dis 14:649. https://doi.org/10.1186/s12879-014-0649-2CrossRefPubMedPubMedCentral

93.

Catania F, Baedke J, Fábregas-Tejeda A, Nieves Delgado A, Vitali V, Long LAN (2021) Global climate change, diet, and the complex relationship between human host and microbiome: Towards an integrated picture. Bioessays 43(6):e2100049. https://doi.org/10.1002/bies.202100049CrossRefPubMed

94.

Jay O, Capon A, Berry P et al (2021) Reducing the health effects of hot weather and heat extremes: from personal cooling strategies to green cities. Lancet 398(10301):709–724. https://doi.org/10.1016/S0140-6736(21)01209-5CrossRefPubMed

95.

Carlsten C, Salvi S, Wong GWK, Chung KF (2020) Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public. Eur Respir J 55(6):1902056. https://doi.org/10.1183/13993003.02056-2019CrossRefPubMedPubMedCentral

96.

diabinfo (2022) Hitze und Diabetes. Available from: www.diabinfo.de/leben/diabetes-im-alltag/hitze.html. Accessed: 6 January 2023 [article in German]

97.

Diabetes UK (2023) Diabetes and hot weather. Available from: www.diabetes.org.uk/guide-to-diabetes/managing-your-diabetes/hot-weather. Accessed: 6 January 2023

98.

Centers for Disease Control and Prevention (2022) Managing diabetes in the heat. Available from: www.cdc.gov/diabetes/library/features/manage-diabetes-heat.html. Accessed: 6 January 2023

99.

Koivisto VA, Fortney S, Hendler R, Felig P (1981) A rise in ambient temperature augments insulin absorption in diabetic patients. Metabolism 30(4):402–405. https://doi.org/10.1016/0026-0495(81)90122-0CrossRefPubMed

100.

Kotcher J, Maibach E, Miller J et al (2021) Views of health professionals on climate change and health: a multinational survey study. Lancet Planet Heal 5(5):e316–e323. https://doi.org/10.1016/S2542-5196(21)00053-XCrossRef

101.

Klonoff DC, Heinemann L, Cook CB et al (2020) The diabetes technology society green diabetes initiative. J Diabetes Sci Technol 14:507–512. https://doi.org/10.1177/1932296820904175CrossRefPubMedPubMedCentral

102.

Guzmán CAF, Aguirre AA, Astle B et al (2021) A framework to guide planetary health education. Lancet Planet Heal 5(5):e253–e255. https://doi.org/10.1016/S2542-5196(21)00110-8CrossRef

103.

IPCC (2022) Climate Change 2022: impacts, adaptation, and vulnerability. Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge University Press, Cambridge, UK and New York, NY, USA

104.

Martinez GS, Kendrovski V, Salazar MA, de’Donato F, Boeckmann M (2022) Heat-health action planning in the WHO European Region: status and policy implications. Environ Res 214(Pt 1):113709. https://doi.org/10.1016/j.envres.2022.113709CrossRefPubMed

105.

Ou Y, West JJ, Smith SJ, Nolte CG, Loughlin DH (2020) Air pollution control strategies directly limiting national health damages in the US. Nat Commun 11(1):957. https://doi.org/10.1038/s41467-020-14783-2CrossRefPubMedPubMedCentral

106.

Li T, Chen C, Cai W (2022) The global need for smart heat-health warning systems. Lancet 400:1511–1512. https://doi.org/10.1016/S0140-6736(22)01974-2CrossRefPubMed

107.

Li L, Cheng W-Y, Glicksberg BS et al (2015) Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med 7(311):311ra174. https://doi.org/10.1126/scitranslmed.aaa9364CrossRefPubMedPubMedCentral

108.

Ahlqvist E, Storm P, Käräjämäki A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6(5):361–369. https://doi.org/10.1016/S2213-8587(18)30051-2CrossRefPubMed

109.

Nair ATN, Wesolowska-Andersen A, Brorsson C et al (2022) Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nat Med 28(5):982–988. https://doi.org/10.1038/s41591-022-01790-7CrossRefPubMed

110.

Zaharia OP, Strassburger K, Strom A et al (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 7(9):684–694. https://doi.org/10.1016/S2213-8587(19)30187-1CrossRefPubMed

111.

Saatmann N, Zaharia OP, Strassburger K et al (2021) Physical fitness and cardiovascular risk factors in the novel diabetes subgroups. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgab810

112.

Herder C, Maalmi H, Strassburger K et al (2021) Differences in biomarkers of inflammation between novel subgroups of recent-onset diabetes. Diabetes 70(5):1198–1208. https://doi.org/10.2337/db20-1054CrossRefPubMed

113.

Ratter-Rieck JM, Maalmi H, Trenkamp S et al (2021) Leukocyte counts and T-cell frequencies differ between novel subgroups of diabetes and are associated with metabolic parameters and biomarkers of inflammation. Diabetes 70(11):2652–2662. https://doi.org/10.2337/db21-0364CrossRefPubMed

114.

Laine JE, Huybrechts I, Gunter MJ et al (2021) Co-benefits from sustainable dietary shifts for population and environmental health: an assessment from a large European cohort study. Lancet Planet Heal 5(11):e786–e796. https://doi.org/10.1016/S2542-5196(21)00250-3CrossRef

Title: Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders
Authors: Jacqueline M. Ratter-Rieck
Michael Roden
Christian Herder
Publication date: 25-03-2023
Publisher: Springer Berlin Heidelberg
Keywords: Insulins
Insulins
Climate Change
Heat Waves
Published in: Diabetologia / Issue 6/2023
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-023-05901-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Graphical abstract

Please log in to get access to this content

Other articles of this Issue 6/2023

Sex differences in type 2 diabetes

Methylation of histone H3 lysine 4 is required for maintenance of beta cell function in adult mice

Significant impact of time-of-day variation on metformin pharmacokinetics

Drug target Mendelian randomisation: are we really instrumenting drug use? Reply to Anderson EL, Williams DM [letter]

Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes

Drug target Mendelian randomisation: are we really instrumenting drug use?

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage